Michail S. Lionakis

Pentamidine is active in vitro against Fusarium species.

Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.

Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.

Glucocorticoids and invasive fungal infections.

The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer.

Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus.

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.

Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

Sinus zygomycosis in a patient receiving voriconazole prophylaxis.

Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.

Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

Fusarium infections in critically ill patients.

Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.

Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis.

Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center.

Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis.

Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.

Role of mini-host models in the study of medically important fungi.

Malaise, weight loss, pleuritic chest pain and productive cough: what is your call?

Endocrine and metabolic manifestations of invasive fungal infections and systemic antifungal treatment.

Organ-specific innate immune responses in a mouse model of invasive candidiasis.

The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment.

Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.

Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology.

Drosophila melanogaster as a model organism for invasive aspergillosis.

Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis.

Genetic Susceptibility to Fungal Infections in Humans.

Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans.

Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice.

Candida and host determinants of susceptibility to invasive candidiasis.

CARD9: at the intersection of mucosal and systemic antifungal immunity.